Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosis.

Theranostics · 2021 · PMC7681091 · PMID 33391475

Europe PMC DOI

hedged sentence

0.7700

closest p · 15.4× alpha

0.7700

boldest claim

The sentences

showed a trendp = 0.77not close (p > 0.1)

In contrast, there was a statistically significant male predominance in the subgroup of patients with SM-AHN, whereas patients with ASM and MCL showed a trend towards male predominance (ASM, 52%, p = 0.77; SM-AHN, 70%, p < 0.001; MCL, 58%, p = 0.360).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.